which already has an FDA green light for its Igalmi (dexmedetomidine) drug in agitation associated with schizophrenia and bipolar disorder, and has a phase 3 programme running in Alzheimer’s ...

A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...

The new Alzheimer’s drug Kinsula is offering hope for patients by slowing down the progression of the disease. Neurologist Dr. Mauricio Concha administered the drug ...

New research reveals a potential breakthrough in Alzheimer’s treatment, showing that the drug troriluzole can reverse memory ...

In a recent breakthrough in Alzheimer’s research, scientists at Auburn University have discovered a new drug, troriluzole, ...

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like ...

Leqembi manufacturers Eisai and Biogen priced the drug ... FDA to help clinicians and patients make informed decisions about the risk of side effects,” says an expert from the Alzheimer’s ...

The first drug found to slow down Alzheimer’s is to be given the green light for use in Britain. Lecanemab, hailed by experts as “the beginning of the end” for the disease, has been found to ...

This is what the drug is designed to do, prohibit these amyloid plaque deposits from forming. Experts say that it is still an open question how Alzheimer’s manifests in people with Down ...

As quantitative data replaced qualitative descriptions in the ads, and as information about severe adverse effects was ...

The treatment involves infusions of a new Alzheimer’s drug, lecanemab, which was approved by the Food and Drug Administration ...